Stock Earnings

Question 1

Aclaris Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Aclaris Therapeutics Incの総資産は$220で、純lossは$-132です。

Question 2

ACRSの主要な財務比率は何ですか？

Accepted Answer

Aclaris Therapeutics Incの流動比率は3.43、純利益率は-733.33、1株当たり売上高は$0.23です。

Question 3

Aclaris Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Aclaris Therapeutics Inc largest revenue segment is Therapeutics, at a revenue of 16,178,999 in the most earnings release.For geography, United States is the primary market for Aclaris Therapeutics Inc, at a revenue of 18,720,000.

Question 4

Aclaris Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Aclaris Therapeutics Incの純lossは$-132です。

Question 5

Aclaris Therapeutics Incに負債はありますか？

Accepted Answer

yes、Aclaris Therapeutics Incの負債は64です。

Question 6

Aclaris Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Aclaris Therapeutics Incの総発行済株式数は107.85株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	15	18	31	29	6	6
Revenue Growth (YoY)	-44%	-42%	7%	383%	0%	50%
Cost of Revenue	15	15	18	11	4	5
Gross Profit	0	3	13	17	2	1
Selling, General & Admin	21	21	31	25	23	20
Research & Development	45	32	98	77	43	31
Operating Expenses	153	55	102	102	67	52
Other Non Operating Income (Expenses)	3	1	8	2	-1	0
Pretax Income	-141	-132	-88	-86	-90	-51
Income Tax Expense	--	0	0	0	0	0
Net Income	-141	-132	-88	-86	-90	-51
Net Income Growth	281%	50%	2%	-4%	76%	-68%
Shares Outstanding (Diluted)	122.61	77.29	69.8	65.21	56.73	42.54
Shares Change (YoY)	72%	11%	7%	15%	33%	3%
EPS (Diluted)	-1.15	-1.7	-1.26	-1.33	-1.6	-1.2
EPS Growth	121%	35%	-5%	-17%	33%	-69%
Free Cash Flow	-79	-56	-79	-68	-52	-39
Free Cash Flow Per Share	-0.64	-0.72	-1.13	-1.04	-0.91	-0.91
Gross Margin	0%	16.66%	41.93%	58.62%	33.33%	16.66%
Operating Margin	-1,019.99%	-288.88%	-287.09%	-293.1%	-1,083.33%	-833.33%
Profit Margin	-940%	-733.33%	-283.87%	-296.55%	-1,500%	-850%
Free Cash Flow Margin	-526.66%	-311.11%	-254.83%	-234.48%	-866.66%	-650%
EBITDA	-153	-52	-89	-85	-65	-49
EBITDA Margin	-1,019.99%	-288.88%	-287.09%	-293.1%	-1,083.33%	-816.66%
D&A For EBITDA	0	0	0	0	0	1
EBIT	-153	-52	-89	-85	-65	-50
EBIT Margin	-1,019.99%	-288.88%	-287.09%	-293.1%	-1,083.33%	-833.33%
Effective Tax Rate	--	0%	0%	0%	0%	0%

Aclaris Therapeutics Inc (ACRS) Price

ACRS Stock Price Chart

ACRS Income

Follow-Up Questions